Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells

Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: A prospective study

(2014) T.P. Zheng et al.   ATHEROSCLEROSIS

Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability

(2014) Adrienne Müller et al.   NUCLEAR MEDICINE AND BIOLOGY

Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima–media thickness

(2013) Changhong Tan et al.   ATHEROSCLEROSIS

Bioinformatics tools for secretome analysis

(2013) Dario Caccia et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability

(2013) Daiane Silvello et al.   BIOMARKERS

Adipose Dipeptidyl Peptidase-4 and Obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro

(2013) H. Sell et al.   DIABETES CARE

Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice

(2013) Nasib Ervinna et al.   ENDOCRINOLOGY

cAMP-response Element-binding Protein (CREB) and NF-κB Transcription Factors Are Activated during Prolonged Hypoxia and Cooperatively Regulate the Induction of Matrix MetalloproteinaseMMP1

(2013) Koh Nakayama   JOURNAL OF BIOLOGICAL CHEMISTRY

Serum SPARC and Matrix Metalloproteinase-2 and Metalloproteinase-9 Concentrations after Bariatric Surgery in Obese Adults

(2013) Yeon Ji Lee et al.   OBESITY SURGERY

Identification and Validation of Novel Contraction-Regulated Myokines Released from Primary Human Skeletal Muscle Cells

(2013) Silja Raschke et al.   PLoS One

The Role of DPP4 Activity in Cardiovascular Districts: In Vivo and In Vitro Evidence

(2013) L. Pala et al.   Journal of Diabetes Research

Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-α

(2012) Yuko Yamamoto et al.   HEART AND VESSELS

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

(2011) D. Lamers et al.   DIABETES

Incretin effect: GLP-1, GIP, DPP4

(2011) Kyriakos Kazakos   DIABETES RESEARCH AND CLINICAL PRACTICE

Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

(2011) Matthew R. Alexander et al.   JOURNAL OF CLINICAL INVESTIGATION

Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1

(2011) Gian Paolo Fadini et al.   VASCULAR PHARMACOLOGY

Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-Dependent Prostate Cancer Cell Migration

(2010) A. L. Sabbota et al.   CANCER RESEARCH

The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: Novel drug targets with therapeutic potential?

(2010) Paul Saftig et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

On the origin of serum CD26 and its altered concentration in cancer patients

(2009) Oscar J. Cordero et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

MMP-1 serum levels predict coronary atherosclerosis in humans

(2009) Michael Lehrke et al.   Cardiovascular Diabetology

The role of hypoxia in atherosclerosis

(2009) Lillemor Mattsson Hultén et al.   CURRENT OPINION IN LIPIDOLOGY

ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis

(2009) X. Lu et al.   GENES & DEVELOPMENT

Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells

(2009) A S Ribeiro et al.   ONCOGENE

Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets

(2009) Stephan Reinboldt et al.   PLATELETS

Matrix Metalloproteinase-2 and -9 Levels in Obese Patients

(2008) G. Derosa et al.   ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH